Yatin Suneja

Stock Analyst at Guggenheim

(1.51)
# 1723
Out of 5,386 analysts
153
Total ratings
Success rate
Average return
46 Stocks
Name Action PT Current % Upside Ratings Updated
LRMR Larimar Therapeutics
Reiterates: Buy
26 26
3.02 760.93% 6 Jun 25, 2025
ALMS Alumis
Reinstates: Buy
18
3.02 496.03% 2 Jun 10, 2025
ANAB AnaptysBio
Maintains: Strong Buy
54 90
22.41 301.61% 13 May 28, 2025
CABA Cabaletta Bio
Maintains: Strong Buy
23 25
1.58 1482.28% 5 May 16, 2025
GHRS GH Research
Maintains: Buy
32 29
12.39 134.06% 1 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
1100 1065
559.65 90.3% 10 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
155 165
125.44 31.54% 5 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 12
9.72 23.46% 4 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
940 810
520.94 55.49% 6 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15 15
1.07 1301.87% 2 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 10
0.83 1104.82% 5 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
0.64 993.75% 1 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 8 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
84 84
17.65 375.92% 1 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
45 45
9.57 370.22% 3 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 3 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
45 45
9.01 399.45% 3 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 20
22.09 -9.46% 6 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
50 65
15.22 327.07% 1 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
155 170
42.97 295.62% 2 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
7.4 575.68% 1 Apr 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
72 90
20.29 343.57% 4 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
110 125
103.39 20.9% 8 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
16 32
n/a n/a 3 Jan 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 16
11.41 40.23% 2 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
70 77
47.34 62.65% 3 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jul 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
49
32.37 51.37% 2 Jun 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
52 55
9.65 469.95% 2 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
270 350
125.95 177.89% 3 May 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
225 200
n/a n/a 3 Apr 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 5 Jan 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
98 117
n/a n/a 1 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
n/a n/a 1 Oct 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Oct 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
12.4 93.55% 1 May 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
29 34
93.84 -63.77% 2 Jan 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
n/a
n/a n/a 1 Feb 22, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
60 80
n/a n/a 2 Jun 11, 2018